Adial Pharmaceuticals Inc
ADIL
Market Cap$5.16M
Close$
$0.20
38.3% downside
Current Fair Value
38.3% downsideOvervalued by 38.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.16 Million |
|---|---|
| Enterprise Value | $3.32 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.71 |
| Beta | 1.19 |
| Outstanding Shares | 18,588,748 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.68 |
|---|---|
| PEG | 1.04 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.38 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Adial Pharmaceuticals Inc
2,018 employees